Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The socioeconomic impact of disability progression in multiple sclerosis: A retrospective cohort study of the German NeuroTransData (NTD) registry.
Dillon P, Heer Y, Karamasioti E, Muros-Le Rouzic E, Marcelli G, Di Maio D, Braune S, Kobelt G, Wasem J. Dillon P, et al. Among authors: muros le rouzic e. Mult Scler J Exp Transl Clin. 2023 Jul 24;9(3):20552173231187810. doi: 10.1177/20552173231187810. eCollection 2023 Jul-Sep. Mult Scler J Exp Transl Clin. 2023. PMID: 37529629 Free PMC article.
Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study.
Weber MS, Buttmann M, Meuth SG, Dirks P, Muros-Le Rouzic E, Eggebrecht JC, Hieke-Schulz S, Leemhuis J, Ziemssen T. Weber MS, et al. Among authors: muros le rouzic e. Front Neurol. 2022 May 9;13:863105. doi: 10.3389/fneur.2022.863105. eCollection 2022. Front Neurol. 2022. PMID: 35614917 Free PMC article.
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry.
Butzkueven H, Spelman T, Horakova D, Hughes S, Solaro C, Izquierdo G, Kubala Havrdová E, Grand'Maison F, Prat A, Girard M, Hupperts R, Onofrj M, Lugaresi A, Taylor B; MSBase Study Group; Giovannoni G, Kappos L, Hauser SL, Montalban X, Craveiro L, Freitas R, Model F, Overell J, Muros-Le Rouzic E, Sauter A, Wang Q, Wormser D, Wolinsky JS. Butzkueven H, et al. Among authors: muros le rouzic e. Eur J Neurol. 2022 Apr;29(4):1082-1090. doi: 10.1111/ene.14824. Epub 2021 May 6. Eur J Neurol. 2022. PMID: 33724638 Free PMC article. Clinical Trial.
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients.
Guerrera G, Mandelli A, Finardi A, Orrico M, D'Orso S, Picozza M, Noviello M, Beretta V, Bonetti B, Calabrese M, Marastoni D, De Rossi N, Capra R, Salvetti M, Buscarinu MC, Inglese M, Uccelli A, Moiola L, Raposo C, Muros-Le Rouzic E, Pedotti R, Filippi M, Bonini C, Battistini L, Borsellino G, Furlan R. Guerrera G, et al. Among authors: muros le rouzic e. Mult Scler. 2022 Oct;28(12):1937-1943. doi: 10.1177/13524585221102158. Epub 2022 Jun 20. Mult Scler. 2022. PMID: 35723265
Adolescents and adults with Fontan circulation: insights from the PREpArE-Fontan registry.
Søndergaard L, Aboulhosn J, d'Udekem Y, Faure C, Franklin WJ, Hager A, Kim YY, Muros-Le Rouzic E, Rosenberg D, Schwerzmann M, Clift P. Søndergaard L, et al. Among authors: muros le rouzic e. Cardiol Young. 2022 Apr;32(4):597-605. doi: 10.1017/S1047951121002791. Epub 2021 Jul 23. Cardiol Young. 2022. PMID: 34294186 Free article.
17 results